NEWGEN - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 4.0
| Stock Code | NEWGEN | Market Cap | 7,198 Cr. | Current Price | 506 ₹ | High / Low | 1,379 ₹ |
| Stock P/E | 22.7 | Book Value | 115 ₹ | Dividend Yield | 0.99 % | ROCE | 26.2 % |
| ROE | 20.8 % | Face Value | 10.0 ₹ | DMA 50 | 500 ₹ | DMA 200 | 721 ₹ |
| Chg in FII Hold | -2.86 % | Chg in DII Hold | -0.83 % | PAT Qtr | 110 Cr. | PAT Prev Qtr | 79.8 Cr. |
| RSI | 60.6 | MACD | 5.39 | Volume | 1,36,34,608 | Avg Vol 1Wk | 49,58,684 |
| Low price | 401 ₹ | High price | 1,379 ₹ | PEG Ratio | 0.95 | Debt to equity | 0.02 |
| 52w Index | 10.7 % | Qtr Profit Var | 8.13 % | EPS | 20.0 ₹ | Industry PE | 21.6 |
📊 Financials: NEWGEN demonstrates strong fundamentals with ROE at 20.8% and ROCE at 26.2%. EPS is ₹20.0, supported by quarterly PAT growth (+8.13%, ₹110 Cr vs ₹79.8 Cr). Debt-to-equity ratio of 0.02 reflects a nearly debt-free balance sheet, enhancing financial stability. Dividend yield of 0.99% provides modest income support.
💹 Valuation: The stock trades at a P/E of 22.7, slightly above the industry average of 21.6, suggesting fair valuation. PEG ratio of 0.95 indicates reasonable growth alignment. Book value of ₹115 provides strong intrinsic backing. Overall, valuation remains balanced compared to peers.
🏭 Business Model: NEWGEN operates in enterprise software solutions, with strengths in workflow automation, digital transformation, and process management. Its competitive advantage lies in niche specialization, strong efficiency metrics, and global demand. However, institutional outflows and sector cyclicality pose risks.
📈 Entry Zone: Attractive entry would be near ₹490–₹500, aligning with support levels and fairer valuation. Current price (₹506) is near the 50 DMA (₹500) but below the 200 DMA (₹721), suggesting short-term stability but medium-term weakness. Long-term investors may accumulate cautiously on dips.
Positive
- Strong ROE (20.8%) and ROCE (26.2%).
- EPS of ₹20.0 provides earnings strength.
- Debt-free balance sheet (0.02 debt-to-equity).
- Quarterly PAT growth (+8.13%).
Limitation
- P/E (22.7) slightly above industry average (21.6).
- Institutional outflows with FII (-2.86%) and DII (-0.83%).
- Stock trading below 200 DMA (₹721), reflecting medium-term weakness.
Company Negative News
- Decline in institutional holdings (FII and DII outflows).
- Medium-term weakness with price below 200 DMA.
Company Positive News
- Quarterly PAT improved to ₹110 Cr (+8.13%).
- Strong efficiency metrics with ROE and ROCE above industry averages.
- Debt-free operations enhance financial stability.
Industry
- Enterprise software sector remains demand-driven with digital transformation tailwinds.
- Industry P/E at 21.6 highlights NEWGEN’s fair valuation.
- Global competition and technology cycles impact profitability.
Conclusion
⚖️ NEWGEN demonstrates strong efficiency, debt-free status, and fair valuation. Entry is favorable near ₹490–₹500 for long-term investors. Current levels suggest cautious accumulation, with better opportunities on dips. Holding is recommended for long-term growth, but monitoring institutional flows and sector cyclicality is essential.